WEREWOLF ®, the WEREWOLF logo, PREDATOR ®, INDUKINE ™ and other Werewolf trademarks, service marks, graphics and logos are trade names, trademarks or registered trademarks of Werewolf Therapeutics, ...

MZE829 Phase 2 HORIZON Trial Enrolling Patients with APOL1 Kidney Disease (AKD); Initial Data Expected in Q1 2026MZE782 Phase 1 Healthy Volunteer ...

Minjuvi ® in combination with lenalidomide, followed by Minjuvi ® monotherapy, is indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), who ...

Monjuvi, Minjuvi, the Minjuvi and Monjuvi logos and the "triangle” design ... Knight's Latin American subsidiaries operate under United Medical, Biotoscana Farma and Laboratorio LKM. Knight ...

MONTREAL, March 26, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight"), a pan-American (ex-US) specialty pharmaceutical company, announced today ...

March 31, 2025 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (MAZE), a clinical ... CKD estimated to affect over one million people in the United States alone. In February 2025, Maze dosed the ...

The global CAR T-cell therapy market is projected to grow from USD 2.7 billion in 2025 to over USD 27.5 billion by 2033, reflecting a robust CAGR of 26.2%.

Dr. von Moltke most recently served as CMO at Seres Therapeutics with functional oversight of clinical ... regulatory approval to commercialize any product candidate in the United States or any other ...

Coalition, the world's first Active Insurance provider designed to prevent digital risk before it strikes, today announced the appointment of Maha Virudhagiri as the company's first Chief Technology ...

United Therapeutics has high revenue growth and low debt. Read why UTHR stock is undervalued with solid financial metrics and ...